| |
| |
|
| Insider
Information: |
Forbes Christopher |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
12,757,318 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,279,719 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
12,757,318 |
|
|
| Total
Value |
$10,279,719 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eloxx Pharmaceuticals Inc |
ELOX |
Director, 10% Owner |
2012-11-26 |
12,757,318 |
2004-01-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • – |
2004-01-23 |
4 |
B |
$0.00 |
$0 |
D/D |
31,646 |
579,569 |
2.31 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-02-19 |
4 |
B |
$0.00 |
$0 |
D/D |
882,381 |
3,044,180 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-07-29 |
4 |
B |
$0.00 |
$0 |
D/D |
177,222 |
618,723 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-02-27 |
4 |
B |
$0.78 |
$78 |
D/D |
100 |
1,949,471 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-05 |
4 |
B |
$0.40 |
$400 |
D/D |
1,000 |
2,064,521 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2012-11-26 |
4 |
B |
$0.16 |
$400 |
D/D |
2,500 |
12,757,318 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-03-10 |
4 |
B |
$0.84 |
$462 |
D/D |
550 |
1,983,121 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-02-29 |
4 |
B |
$0.79 |
$711 |
D/D |
900 |
1,950,371 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-12 |
4 |
B |
$0.36 |
$720 |
D/D |
2,000 |
2,079,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-10 |
4 |
B |
$0.37 |
$925 |
D/D |
2,500 |
2,077,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-02 |
4 |
B |
$0.37 |
$1,036 |
D/D |
2,800 |
2,051,821 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-02-26 |
4 |
B |
$0.40 |
$1,600 |
D/D |
4,000 |
2,044,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-03 |
4 |
B |
$0.39 |
$1,650 |
D/D |
4,200 |
2,056,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-02-27 |
4 |
B |
$0.39 |
$1,980 |
D/D |
5,000 |
2,049,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-16 |
4 |
B |
$0.46 |
$2,287 |
D/D |
4,800 |
2,094,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-12-12 |
4 |
B |
$0.60 |
$2,400 |
D/D |
4,000 |
2,036,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-03-13 |
4 |
B |
$0.88 |
$2,464 |
D/D |
2,800 |
2,010,921 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-12-16 |
4 |
B |
$0.70 |
$2,880 |
D/D |
4,000 |
2,040,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-04 |
4 |
B |
$0.38 |
$2,960 |
D/D |
7,500 |
2,063,521 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-09 |
4 |
B |
$0.38 |
$3,800 |
D/D |
10,000 |
2,074,521 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-12-15 |
4 |
B |
$0.60 |
$3,929 |
D/D |
6,000 |
2,036,021 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2009-03-13 |
4 |
B |
$0.39 |
$3,978 |
D/D |
10,200 |
2,089,221 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2011-03-22 |
4 |
B |
$0.28 |
$4,191 |
D/D |
15,000 |
7,452,289 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-02-25 |
4 |
B |
$0.76 |
$7,723 |
D/D |
10,000 |
1,934,171 |
3.84 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
Director |
– • • |
2008-03-12 |
4 |
B |
$0.84 |
$8,884 |
D/D |
10,100 |
2,008,121 |
3.84 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
